Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
John GF Cleland*, Justin Ghosh and Nick Freemantle
Correspondence *Academic Cardiology Unit, University of Hull, Castle Hill Hospital, Castle Road, Cottingham, Kingston upon Hull, HU16 5JQ, UK
Email J.G.Cleland@hull.ac.uk
This article has no abstract so we have provided the first paragraph of the full text.
The COMPANION trial findings suggest that CRT alone or combined with a defibrillator might reduce morbidity and mortality in patients with cardiac dys-synchrony and chronic heart failure (CHF). When viewed in isolation, however, the results are inconclusive and their interpretation for clinical practice problematic. This issue needs to be resolved by further large trials.1, 2
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
